• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低分子量岩藻聚糖硫酸酯通过调节肾脏脂代谢抑制糖尿病肾脏纤维化。

Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism.

机构信息

College of Pharmacy, Linyi University, Linyi, Shandong, China.

Linyi Tumor Hospital, Linyi, Shandong, China.

出版信息

J Diabetes Res. 2021 Nov 24;2021:7618166. doi: 10.1155/2021/7618166. eCollection 2021.

DOI:10.1155/2021/7618166
PMID:34869779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8635909/
Abstract

In this study, a diabetic kidney disease model was established by placing the test rats on a high-sugar/high-fat diet combined with streptozotocin induction. Histopathological examination (H&E, Masson, and PASM stain) showed pathological changes in the diabetic rat kidneys, in addition to fibrotic symptoms and collagen deposition. Immunohistochemistry and western blot analyses indicated that the diabetic condition significantly increased the expressions of fibrotic markers including collagen, -SMA, and fibronectin. The levels of cholesterol, triglyceride, and low-density lipoprotein were also increased in diabetic kidney disease (DKD) rat blood, while the level of high-density lipoprotein was decreased. The results of Oil red O staining experiments indicated that the kidneys of diabetic rats exhibited appreciable fat deposition, with high contents of triglyceride and cholesterol. To inhibit fibrosis and reduce fat deposition, low molecular weight fucoidan (LMWF) may be used. Based on PCR and western blot analyses, LMWF can regulate the expression levels of important lipid metabolism regulators, thereby impeding the development of kidney fibrosis. Through the vitro model, it also be indicated that LMWF could inhibit fibrosis process through regulating lipid metabolism which induced by palmitic acid.

摘要

在这项研究中,通过给予实验大鼠高糖/高脂肪饮食联合链脲佐菌素诱导建立了糖尿病肾病模型。组织病理学检查(H&E、Masson 和 PASM 染色)显示,糖尿病大鼠肾脏出现了病理性变化,此外还有纤维化症状和胶原沉积。免疫组织化学和 Western blot 分析表明,糖尿病状态显著增加了纤维化标志物的表达,包括胶原、-SMA 和纤维连接蛋白。糖尿病肾病(DKD)大鼠血液中的胆固醇、甘油三酯和低密度脂蛋白水平也升高,而高密度脂蛋白水平降低。油红 O 染色实验的结果表明,糖尿病大鼠的肾脏表现出明显的脂肪沉积,甘油三酯和胆固醇含量高。为了抑制纤维化和减少脂肪沉积,可以使用低分子量褐藻糖胶(LMWF)。基于 PCR 和 Western blot 分析,LMWF 可以调节重要脂质代谢调节剂的表达水平,从而阻碍肾脏纤维化的发展。通过体外模型,还表明 LMWF 可以通过调节棕榈酸诱导的脂质代谢来抑制纤维化过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/c663af8020a6/JDR2021-7618166.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/c9174d6a6137/JDR2021-7618166.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/414f456854ea/JDR2021-7618166.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/04684fd4aee4/JDR2021-7618166.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/c663af8020a6/JDR2021-7618166.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/c9174d6a6137/JDR2021-7618166.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/414f456854ea/JDR2021-7618166.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/04684fd4aee4/JDR2021-7618166.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cea/8635909/c663af8020a6/JDR2021-7618166.004.jpg

相似文献

1
Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism.低分子量岩藻聚糖硫酸酯通过调节肾脏脂代谢抑制糖尿病肾脏纤维化。
J Diabetes Res. 2021 Nov 24;2021:7618166. doi: 10.1155/2021/7618166. eCollection 2021.
2
[Role and mechanism of tranilast preventing the progression of tubulointerstilial fibrosis in diabetic kidney diseases].曲尼司特预防糖尿病肾病肾小管间质纤维化进展的作用及机制
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Dec;38(12):1233-42. doi: 10.3969/j.issn.1672-7347.2013.12.006.
3
MiR-135a regulates renal fibrosis in rats with diabetic kidney disease through the Notch pathway.miR-135a 通过 Notch 通路调控糖尿病肾病大鼠肾脏纤维化。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1979-1987. doi: 10.26355/eurrev_202002_20375.
4
Low Molecular Weight Fucoidan Inhibits Pulmonary Fibrosis In Vivo and In Vitro via Antioxidant Activity.低分子量岩藻聚糖硫酸酯通过抗氧化活性抑制体内和体外肺纤维化。
Oxid Med Cell Longev. 2022 Mar 2;2022:7038834. doi: 10.1155/2022/7038834. eCollection 2022.
5
Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats.低分子量岩藻依聚糖改善1型糖尿病大鼠中链脲佐菌素诱导的主动脉平滑肌高反应性。
J Ethnopharmacol. 2016 Sep 15;191:341-349. doi: 10.1016/j.jep.2016.06.054. Epub 2016 Jun 21.
6
Therapeutic Role of Tangshenkang Granule () in Rat Model with Diabetic Nephropathy.糖肾康颗粒()对糖尿病肾病大鼠模型的治疗作用
Chin J Integr Med. 2018 Aug;24(8):600-605. doi: 10.1007/s11655-016-2607-x. Epub 2016 Oct 24.
7
Fucoidan mitigated diabetic nephropathy through the downregulation of PKC and modulation of NF-κB signaling pathway: in vitro and in vivo investigations.岩藻聚糖硫酸酯通过下调 PKC 及调控 NF-κB 信号通路减轻糖尿病肾病:体外和体内研究。
Phytother Res. 2021 Apr;35(4):2133-2144. doi: 10.1002/ptr.6966. Epub 2020 Dec 2.
8
Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.低相对分子质量岩藻聚糖硫酸酯通过抑制血管内皮生长因子减轻链脲佐菌素诱导的糖尿病视网膜病变。
Exp Eye Res. 2013 Oct;115:96-105. doi: 10.1016/j.exer.2013.06.011. Epub 2013 Jun 28.
9
Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs.依布列磷对饮食诱导的糖尿病小型猪肾脏脂类蓄积的抑制和脂蛋白脂酶的增加的预防作用。
Lipids Health Dis. 2011 Jul 16;10:117. doi: 10.1186/1476-511X-10-117.
10
Laminaria japonica Polysaccharide Regulates Fatty Hepatosis Through Bile Acids and Gut Microbiota in Diabetes Rat.海带多糖通过胆汁酸和肠道微生物群调节糖尿病大鼠的脂肪性肝病。
Mar Biotechnol (NY). 2024 Dec;26(6):1165-1178. doi: 10.1007/s10126-024-10365-1. Epub 2024 Aug 29.

引用本文的文献

1
Renal Health Through Medicine-Food Homology: A Comprehensive Review of Botanical Micronutrients and Their Mechanisms.通过药食同源促进肾脏健康:植物性微量营养素及其作用机制的综合综述
Nutrients. 2024 Oct 18;16(20):3530. doi: 10.3390/nu16203530.
2
Laminaria japonica Polysaccharide Regulates Fatty Hepatosis Through Bile Acids and Gut Microbiota in Diabetes Rat.海带多糖通过胆汁酸和肠道微生物群调节糖尿病大鼠的脂肪性肝病。
Mar Biotechnol (NY). 2024 Dec;26(6):1165-1178. doi: 10.1007/s10126-024-10365-1. Epub 2024 Aug 29.
3
MicroRNA-345-3p is a potential biomarker and ameliorates rheumatoid arthritis by reducing the release of proinflammatory cytokines.

本文引用的文献

1
Fucoidan mitigated diabetic nephropathy through the downregulation of PKC and modulation of NF-κB signaling pathway: in vitro and in vivo investigations.岩藻聚糖硫酸酯通过下调 PKC 及调控 NF-κB 信号通路减轻糖尿病肾病:体外和体内研究。
Phytother Res. 2021 Apr;35(4):2133-2144. doi: 10.1002/ptr.6966. Epub 2020 Dec 2.
2
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
3
miR-345-3p 是一种潜在的生物标志物,通过减少促炎细胞因子的释放来改善类风湿关节炎。
J Orthop Surg Res. 2023 Jun 1;18(1):399. doi: 10.1186/s13018-023-03797-3.
4
Low Molecular Weight Fucoidan Inhibits Pulmonary Fibrosis In Vivo and In Vitro via Antioxidant Activity.低分子量岩藻聚糖硫酸酯通过抗氧化活性抑制体内和体外肺纤维化。
Oxid Med Cell Longev. 2022 Mar 2;2022:7038834. doi: 10.1155/2022/7038834. eCollection 2022.
Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells.
低分子量岩藻聚糖硫酸酯通过与人肾系膜细胞中纤维连接蛋白结合并抑制细胞外基质-受体相互作用来减轻糖尿病肾病。
Int J Biol Macromol. 2020 May 1;150:304-314. doi: 10.1016/j.ijbiomac.2020.02.087. Epub 2020 Feb 11.
4
UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury.UCP2 诱导的低氧促进缺血性肾损伤过程中的脂质积累和小管间质纤维化。
Cell Death Dis. 2020 Jan 13;11(1):26. doi: 10.1038/s41419-019-2219-4.
5
Lipid Metabolism Disorder and Renal Fibrosis.脂代谢紊乱与肾纤维化。
Adv Exp Med Biol. 2019;1165:525-541. doi: 10.1007/978-981-13-8871-2_26.
6
FABP4 contributes to renal interstitial fibrosis via mediating inflammation and lipid metabolism.脂肪细胞型脂肪酸结合蛋白 4 通过介导炎症和脂质代谢促进肾间质纤维化。
Cell Death Dis. 2019 May 16;10(6):382. doi: 10.1038/s41419-019-1610-5.
7
Effects of high-fat diet on growth performance, lipid accumulation and lipid metabolism-related MicroRNA/gene expression in the liver of grass carp (Ctenopharyngodon idella).高脂饮食对草鱼(Ctenopharyngodon idella)肝脏生长性能、脂质积累及脂质代谢相关微小RNA/基因表达的影响
Comp Biochem Physiol B Biochem Mol Biol. 2019 Aug;234:34-40. doi: 10.1016/j.cbpb.2019.04.006. Epub 2019 May 6.
8
China Kidney Disease Network (CK-NET) 2015 Annual Data Report.中国肾脏病网(CK-NET)2015年度数据报告。
Kidney Int Suppl (2011). 2019 Mar;9(1):e1-e81. doi: 10.1016/j.kisu.2018.11.001. Epub 2019 Feb 20.
9
PPARγ maintains the metabolic heterogeneity and homeostasis of renal tubules.过氧化物酶体增殖物激活受体 γ 维持肾小管代谢异质性和内稳态。
EBioMedicine. 2018 Dec;38:178-190. doi: 10.1016/j.ebiom.2018.10.072. Epub 2018 Nov 9.
10
Lipid management in patients with chronic kidney disease.慢性肾脏病患者的血脂管理。
Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9.